• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多中心分析肝切除术治疗老年肝细胞癌患者的长期肿瘤学结果。

Multicenter analysis of long-term oncologic outcomes of hepatectomy for elderly patients with hepatocellular carcinoma.

机构信息

Department of Hepatobiliary Surgery, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China.

Department of General Surgery, Liuyang People's Hospital, Hunan, China.

出版信息

HPB (Oxford). 2020 Sep;22(9):1314-1323. doi: 10.1016/j.hpb.2019.12.006. Epub 2020 Jan 21.

DOI:10.1016/j.hpb.2019.12.006
PMID:31980306
Abstract

BACKGROUND

Aging of the population and prolonged life expectancy have significantly increased the number of elderly patients undergoing hepatectomy for hepatocellular carcinoma (HCC). However, potential benefits, especially long-term oncologic outcomes of hepatectomy for elderly patients with HCC remain unclear.

METHOD

Patients treated with curative-intent hepatectomy for HCC in 8 Chinese hospitals were enrolled. Patients were divided into the elderly (≥70 years old) and younger (<70 years old) groups. Overall survival (OS), cancer-specific survival (CSS), and time-to-recurrence (TTR) were compared. Risk factors of CSS and TTR were evaluated by univariable and multivariable competing-risk regression analyses.

RESULTS

Of 2134 patients, 259 (12.1%) and 1875 (87.9%) were elderly and younger aged, respectively. Postoperative 30-day and 90-day mortality was comparable among elderly and younger patients. Compared with younger patients, the elderly had a worse 5-year OS (49.4% vs. 55.3%, P = 0.032), yet a better 5-year CCS (74.5% vs. 61.0%, P = 0.005) and a lower 5-year TTR (33.7% vs. 44.9%, P < 0.001), respectively. Multivariable analyses identified that elder age was independently associated with more favorable CSS (HR 0.74, 95%CI 0.58-0.90, P = 0.011) and TTR (0.69, 0.53-0.88, P < 0.001) but was not associated with OS (P = 0.136).

CONCLUSIONS

Age by itself is not a contraindication to surgery, and selected elderly patients with HCC can benefit from hepatectomy. Compared with younger patients, elderly patients have noninferior oncologic outcomes following hepatectomy for HCC.

摘要

背景

人口老龄化和预期寿命的延长显著增加了因肝细胞癌(HCC)而行肝切除术的老年患者数量。然而,老年 HCC 患者行肝切除术的潜在益处,特别是长期肿瘤学结局仍不明确。

方法

本研究纳入了 8 家中国医院接受根治性肝切除术治疗 HCC 的患者。患者分为老年(≥70 岁)和年轻(<70 岁)两组。比较总生存期(OS)、癌症特异性生存期(CSS)和无复发生存时间(TTR)。采用单变量和多变量竞争风险回归分析评估 CSS 和 TTR 的危险因素。

结果

在 2134 例患者中,259 例(12.1%)和 1875 例(87.9%)为老年和年轻患者。老年和年轻患者术后 30 天和 90 天死亡率相当。与年轻患者相比,老年患者的 5 年 OS 较差(49.4% vs. 55.3%,P=0.032),但 5 年 CSS 更好(74.5% vs. 61.0%,P=0.005)和 5 年 TTR 更低(33.7% vs. 44.9%,P<0.001)。多变量分析确定,年龄较大与 CSS(HR 0.74,95%CI 0.58-0.90,P=0.011)和 TTR(0.69,0.53-0.88,P<0.001)的改善独立相关,但与 OS 无关(P=0.136)。

结论

年龄本身并不是手术的禁忌症,选择合适的老年 HCC 患者可以从肝切除术中获益。与年轻患者相比,老年患者行 HCC 肝切除术后的肿瘤学结局非劣效。

相似文献

1
Multicenter analysis of long-term oncologic outcomes of hepatectomy for elderly patients with hepatocellular carcinoma.多中心分析肝切除术治疗老年肝细胞癌患者的长期肿瘤学结果。
HPB (Oxford). 2020 Sep;22(9):1314-1323. doi: 10.1016/j.hpb.2019.12.006. Epub 2020 Jan 21.
2
Postoperative morbidity adversely impacts long-term oncologic prognosis following hepatectomy for hepatocellular carcinoma: A multicenter observational study.肝癌肝切除术后的术后发病率对长期肿瘤学预后不利:一项多中心观察性研究。
Eur J Surg Oncol. 2021 Oct;47(10):2551-2560. doi: 10.1016/j.ejso.2021.04.027. Epub 2021 Apr 26.
3
Long-term outcomes in elderly patients with resectable large hepatocellular carcinoma undergoing hepatectomy.可切除性大肝细胞癌老年患者肝切除术后的长期预后
Surg Oncol. 2018 Sep;27(3):595-601. doi: 10.1016/j.suronc.2018.07.009. Epub 2018 Jul 17.
4
The efficacy and safety of totally laparoscopic hepatectomy for non-cirrhotic hepatocellular carcinoma in the elderly.老年非肝硬化肝细胞癌全腹腔镜肝切除术的疗效与安全性
BMC Surg. 2018 Dec 17;18(1):118. doi: 10.1186/s12893-018-0444-x.
5
Major Hepatectomy in Elderly Patients with Large Hepatocellular Carcinoma: A Multicenter Retrospective Observational Study.老年大肝细胞癌患者的肝大部切除术:一项多中心回顾性观察研究
Cancer Manag Res. 2020 Jul 9;12:5607-5618. doi: 10.2147/CMAR.S258150. eCollection 2020.
6
The impact of age and ageing on hepatocarcinoma surgery: Short- and long-term outcomes in a multicentre propensity-matched cohort.年龄和衰老对肝癌手术的影响:多中心倾向匹配队列的短期和长期结果。
Liver Int. 2019 May;39(5):894-904. doi: 10.1111/liv.14075. Epub 2019 Mar 26.
7
Liver Regeneration After Major Liver Resection for Hepatocellular Carcinoma in the Elderly.老年肝细胞癌患者肝大部切除术后的肝再生
J Invest Surg. 2020 Apr;33(4):332-338. doi: 10.1080/08941939.2018.1517839. Epub 2018 Nov 2.
8
Prognostic factors of disease-free and overall survival in patients with hepatocellular carcinoma undergoing partial hepatectomy in curative intent.根治性意向下接受部分肝切除术的肝细胞癌患者无病生存和总生存的预后因素。
Langenbecks Arch Surg. 2018 Nov;403(7):851-861. doi: 10.1007/s00423-018-1715-9. Epub 2018 Sep 28.
9
Liver resection in elderly patients with hepatocellular carcinoma: age does matter.老年肝细胞癌患者的肝切除术:年龄确实很重要。
Updates Surg. 2021 Aug;73(4):1371-1380. doi: 10.1007/s13304-021-01021-7. Epub 2021 Mar 9.
10
Validation of hepatectomy for elderly patients with hepatocellular carcinoma.老年肝细胞癌患者肝切除术的验证
Ann Surg Oncol. 2015 Sep;22(9):3094-101. doi: 10.1245/s10434-014-4350-x. Epub 2015 Jan 13.

引用本文的文献

1
Association of preoperative frailty with short- and long-term outcomes after hepatic resection for elderly patients with hepatocellular carcinoma: multicentre analysis.老年肝细胞癌患者肝切除术后术前衰弱与短期和长期预后的相关性:多中心分析
BJS Open. 2024 Dec 30;9(1). doi: 10.1093/bjsopen/zrae171.
2
Prognostic Value of the ASAP Score for Patients Undergoing Hepatic Resection for Hepatocellular Carcinoma: A Multicenter Analysis of 1,239 Patients.ASAP评分对肝细胞癌肝切除患者的预后价值:1239例患者的多中心分析
J Clin Exp Hepatol. 2025 May-Jun;15(3):102497. doi: 10.1016/j.jceh.2024.102497. Epub 2024 Dec 31.
3
Liver resection for hepatocellular carcinoma in elderly patients: does age matter?
老年肝细胞癌患者的肝切除术:年龄重要吗?
BMC Surg. 2024 Sep 5;24(1):248. doi: 10.1186/s12893-024-02528-7.
4
Safety and feasibility of liver resection including major hepatectomy for geriatric patients with hepatocellular carcinoma: a retrospective observational study.老年肝细胞癌患者行肝切除术(包括大范围肝切除术)的安全性和可行性:一项回顾性观察研究。
BMC Cancer. 2024 Jun 26;24(1):765. doi: 10.1186/s12885-024-12514-0.
5
Efficacy and Safety of Surgical Resection in Elderly Patients with Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.老年肝细胞癌患者手术切除的疗效和安全性:系统评价和荟萃分析。
Gut Liver. 2024 Jul 15;18(4):695-708. doi: 10.5009/gnl230485. Epub 2024 May 7.
6
A new method for predicting the microvascular invasion status of hepatocellular carcinoma through neural network analysis.通过神经网络分析预测肝细胞癌微血管侵犯状态的新方法。
BMC Surg. 2023 Apr 28;23(1):100. doi: 10.1186/s12893-023-01967-y.
7
Characteristics and Outcomes of Elderly Hepatocellular Carcinoma Patients following Surgical Resection: Systematic Review and Meta-Analysis.老年肝细胞癌患者手术切除后的特征与结局:系统评价与Meta分析
Dig Dis. 2025;43(2):206-214. doi: 10.1159/000530101. Epub 2023 Mar 13.
8
Short- and Long-Term Outcomes After Hepatectomy in Elderly Patients with Hepatocellular Carcinoma: An Analysis of 229 Cases from a Developing Country.老年肝细胞癌患者肝切除术后的短期和长期预后:来自一个发展中国家的229例病例分析
J Hepatocell Carcinoma. 2021 Mar 23;8:155-165. doi: 10.2147/JHC.S297296. eCollection 2021.
9
Synergistic Impact of Alpha-Fetoprotein and Tumor Burden on Long-Term Outcomes Following Curative-Intent Resection of Hepatocellular Carcinoma.甲胎蛋白与肿瘤负荷对肝细胞癌根治性切除术后长期预后的协同影响
Cancers (Basel). 2021 Feb 11;13(4):747. doi: 10.3390/cancers13040747.
10
Therapeutic Decision Making in Hepatocellular Carcinoma According to Age and Child-Pugh Class: A Nationwide Cohort Analysis in South Korea.根据年龄和 Child-Pugh 分级制定肝细胞癌的治疗决策:韩国全国队列分析。
Can J Gastroenterol Hepatol. 2021 Jan 4;2021:6640121. doi: 10.1155/2021/6640121. eCollection 2021.